Next Article in Journal
Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics
Next Article in Special Issue
Crystal Structure of a Classical MHC Class I Molecule in Dogs; Comparison of DLA-88*0 and DLA-88*5 Category Molecules
Previous Article in Journal
Estrogen Mediates the Sexual Dimorphism of GT1b-Induced Central Pain Sensitization
Previous Article in Special Issue
MHC Class II Presentation in Autoimmunity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cells
Volume 12
Issue 5
10.3390/cells12050809
cells-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Large-Scale Polymorphism Analysis of Dog Leukocyte Antigen Class I and Class II Genes (DLA-88, DLA-12/88L and DLA-DRB1) and Comparison of the Haplotype Diversity between Breeds in Japan

by
Jiro Miyamae
1,*,
Masaharu Okano
2,
Fumihiko Katakura
3,
Jerzy K. Kulski
4,
Tadaaki Moritomo
3 and
Takashi Shiina
4
1
Faculty of Veterinary Medicine, Okayama University of Science, 1-3 Ikoino-oka, Imabari 794-8555, Japan
2
Department of Legal Medicine, Nihon University School of Dentistry, 1-8-13 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-8310, Japan
3
Department of Veterinary Medicine, College of Bioresource Science, Nihon University, 1866 Kameino, Fujisawa 252-0880, Japan
4
Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1143, Japan
*
Author to whom correspondence should be addressed.
Cells 2023, 12(5), 809; https://doi.org/10.3390/cells12050809
Submission received: 28 November 2022 / Revised: 21 February 2023 / Accepted: 2 March 2023 / Published: 6 March 2023
(This article belongs to the Special Issue Major Histocompatibility Complex (MHC) in Health and Disease 2022)
Browse Figures
Versions Notes

Abstract

:
Polymorphisms of canine leukocyte antigen (DLA) class I (DLA-88 and DLA-12/88L) and class II (DLA-DRB1) genes are important for disease susceptibility studies, but information on the genetic diversity among dog breeds is still lacking. To better elucidate the polymorphism and genetic diversity between breeds, we genotyped DLA-88, DLA-12/88L, and DLA-DRB1 loci using 829 dogs of 59 breeds in Japan. Genotyping by Sanger sequencing identified 89, 43, and 61 alleles in DLA-88, DLA-12/88L, and DLA-DRB1 loci, respectively, and a total of 131 DLA-88–DLA-12/88L–DLA-DRB1 haplotypes (88-12/88L-DRB1) were detected more than once. Of the 829 dogs, 198 were homozygotes for one of the 52 different 88-12/88L-DRB1 haplotypes (homozygosity rate: 23.8%). Statistical modeling suggests that 90% of the DLA homozygotes or heterozygotes with one or other of the 52 different 88-12/88L-DRB1 haplotypes within somatic stem cell lines would benefit graft outcome after 88-12/88L-DRB1-matched transplantation. As previously reported for DLA class II haplotypes, the diversity of 88-12/88L-DRB1 haplotypes varied remarkably between breeds but was relatively conserved within most breeds. Therefore, the genetic characteristics of high DLA homozygosity rate and poor DLA diversity within a breed are useful for transplantation therapy, but they may affect biological fitness as homozygosity progresses.

1. Introduction

The major histocompatibility complex (MHC) molecules play important roles in inducing acquired immunity by presenting peptides derived from foreign antigens, such as germs and viruses that T cells recognize as non-self, resulting in the elimination of these antigens. The MHC molecules are classified into class I (MHC-I) and class II (MHC-II), and regulate self- and non-self discrimination in immunity by presenting antigen peptides to CD8+ and CD4+ T cells, respectively [1,2]. The MHC genes encoding MHC-I and MHC-II molecules are composed of multigene families; each of them is extremely polymorphic in many animals. For example, so far, more than 34,000 human leukocyte antigen (HLA) alleles have been identified and reported in the IPD-IMGT database (https://www.ebi.ac.uk/ipd/imgt/hla/ (accessed on 28 November 2022)). In addition, specific HLA alleles associated with susceptibility or resistance to various diseases [3,4,5] and matching of HLA polymorphisms between donor and recipient in transplantation are important factors for suppressing alloimmune responses [6,7,8,9].
The domesticated dog (Canis lupus familiaris) is one of the major companion animals of humans that also is used for biomedical research, such as on the pathobiology of cancers and autoimmune diseases, whose clinical phenotypes (presentations) are similar to those in humans, and in transplantation studies as a preclinical model [10,11]. A draft of the dog genome sequence was determined in the early 2000s, and the dog leukocyte antigen (DLA) loci were located on two chromosome (chr) segments, chr 12 and chr 18 [12,13]. Overall, three DLA class I (DLA-I) loci (DLA-88, DLA-12, and DLA-64) and four DLA class II (DLA-II) loci (DLA-DRA, DLA-DRB1, DLA-DQA1, and DLA-DQB1) were mapped on chr 12, and one divergent DLA-I locus DLA-79 was mapped on chr 18.
To date, 173 DLA-I and 297 DLA-II alleles have been identified and released by the Canine MHC Nomenclature Committee into the IPD-MHC database (https://www.ebi.ac.uk/ipd/mhc/group/DLA/ (accessed on 28 November 2022)). Of the 173 DLA-I alleles identified in several polymorphism studies using more than 500 dogs in total, 139, 17, 9, and 8 alleles were identified in the DLA-88, DLA-12, DLA-64, and DLA-79 loci, respectively [14,15,16,17,18]. In contrast, the polymorphism analyses of the class II region, using more than 10,000 dogs of over 200 breeds, identified 1, 181, 30, and 86 alleles in DLA-DRA, DLA-DRB1, DLA-DQA1, and DLA-DQB1 loci, respectively [19,20,21,22]. Genetic diversity of the DLA-II haplotypes with linked DLA-DRB1, DLA-DQA1, and DLA-DQB1 alleles has been analyzed extensively in various dog breeds. Kennedy et al. reported that DLA polymorphisms are relatively limited within a dog breed, but there are significant differences in the types and frequencies of the DLA-II haplotypes between dog breeds [20,21,22]. In addition, there are reports on DLA-88–DLA-DRB1 haplotypes in the Beagle, DLA-88–DLA-DRB1–DLA-DQA1–DLA-DQB1 haplotypes in the German shepherd dog and some other dog breeds [22,23,24].
Several PCR-based genotyping methods for the DLA-II genes were established, and specific DLA-II polymorphisms were associated to various diseases such as rheumatoid arthritis [25], diabetes mellitus [26,27], and chronic enteritis [28] by case-control studies in various dog breeds. In contrast, though the association between DLA-79 polymorphisms and multiple immune-mediated diseases was reported, there were no clear associations found between polymorphisms of the other DLA-I genes and disease except for an association with pancreatic acinar atrophy in German Shepherds [23,29].
A reason for this limited association of DLA-I polymorphisms with different dog diseases might be that a locus-specific DLA-I genotyping method for association studies had not been established properly because copy number variations of the DLA-I genes per haploid were unknown. In this regard, we recently found that a gene conversion event between DLA-88 and DLA-12 had generated a hybrid DLA-I locus DLA-88L, resulting in two distinct DLA-I haplotype structures, DLA-88–DLA-12–DLA-64 and DLA-88–DLA-88L–DLA-64 [18,30] (Figure 1A). We describe these two alternative haplotypes as the 88-12/88L-64 haplotypes. We also developed a polymorphism analysis method to separate the DLA-88 and DLA-12/88L alleles based on their genomic structures [30]. However, no simple technology was developed to efficiently separate the DLA-12 and DLA-88L alleles from each other (DLA-12/88L), until the present study (Figure 1B). Thus, there are few published studies on the genetic diversity of different combinations of DLA-I and DLA-II polymorphisms in various breeds.
In this study, to characterize the intra- and inter-breed DLA diversity, including both DLA-I and DLA-II genes in various breeds, we developed a new genotyping method to separate DLA-12 from DLA-88L accurately and performed polymorphism analysis of the relatively polymorphic DLA-I genes, DLA-88 and DLA-12/88L, and the most polymorphic DLA-II gene, DLA-DRB1, using 829 dogs of 59 breeds that were collected in Japan. We also estimated three-locus DLA-88–DLA-12/88L–DLA-DRB1 haplotypes (88-12/88L-DRB1) from the detected allele information and evaluated the genetic diversity within and between breeds based on the three-locus haplotype frequency. Furthermore, since the DLA-88, DLA-12/88L, and DLA-DRB1 genes have the characteristics of classical MHC genes such as HLA-A, HLA-B, and HLA-DRB1, their DLA polymorphisms are thought to play important roles for the allo-recognition mechanism during transplantation. Hence, to evaluate the possibility of 88-12/88L-DRB1-matched transplantation using somatic stem cells in the field of veterinary medicine, we simulated statistically the proportion of recipient dogs that possibly could undergo 88-12/88L-DRB1-matched transplantation of somatic stem cells if these cells were established from the 88-12/88L-DRB1 homozygotes.

2. Materials and Methods

2.1. RNA and DNA Samples

Peripheral blood samples from 829 dogs of 59 breeds were collected from the Animal Medical Center (ANMEC) at Nihon University, Marble Veterinary Medical center, and the Nippon Veterinary and Life Science University in accordance with the guidelines for animal experiments specific to each location when the dog owner approved to use the blood for research. Of these, 403 were genotyped initially using RNA samples extracted in the previous study [18,30], and the remaining 426 were genotyped using newly extracted genomic DNA samples (Table 1). We initially genotyped RNA samples (converted to cDNA for amplification) because transcribed MHC genes and alleles are detected more easily without contamination of amplicons originating from pseudogenes or duplicated genes if primer locations crossover to at least two homologous locations. Limitations of the RNA-based genotyping method [15,18] were corrected by also genotyping genomic DNA samples.
The genomic DNA was extracted from peripheral blood mononuclear cells by using TRIzol LS Reagent (Invitrogen/Life Technologies/Thermo Fisher Scientific, Carlsbad, CA, USA) or Kaneka Easy DNA Extraction Kit version 2 (Kaneka Corporation, Hyogo, Japan) according to the manufacturer’s protocols.

2.2. PCR Amplification of DLA-88 and DLA-12/88L Genes

Polymorphism analysis for DLA-88 and DLA-12/88L was performed using the genomic DNA from 426 dogs obtained for this study and 403 dogs that already were genotyped in our previous study [18].
The first PCR was performed independently using a specific primer set (88-seg-F and 88-seg-R2) to amplify the 4.0 kb genomic region, including DLA-88 and using a specific primer set (88L/12-seg-F and 88L/12-seg-R) to amplify the 5.6 kb genomic region including DLA-12/88L (Figure 1B and Supplementary Table S1A). The composition of the PCR solution was 20 ng of DNA, 0.4 unit of KOD FX DNA polymerase (TOYOBO, Osaka, Japan), 10 uL of 2× PCR buffer, 2 mM of dNTP and 0.4 uM of each primer in 20 uL. The cycling parameter was as follows: an initial denaturation with 94 °C/1 min followed by 33 cycles of 98 °C/10 s, 63 °C/30 s, and 68 °C/4 min for DLA-88 and 98 °C/10 s, 58 °C/30 s, and 68 °C/5 min for DLA-12/88L. After the PCR products were purified using ExoSAP-IT (GE Healthcare, Piscataway, NJ, USA) and diluted, the 2nd PCR to distinguish between DLA-12 and DLA-88L alleles was performed using a DLA-12 specific primer set (12-F and 88/12/88L-R) and a DLA-88 and DLA-88L specific primer set (88/88L-F and 88/12/88L-R) (Supplementary Table S1B) [15,18]. The composition of the PCR solution was 1 uL of the first PCR product diluted 1000-fold, 0.4 unit of KOD FX DNA polymerase, 10 μL of 2× PCR buffer, 2 mM of dNTP, and 0.4 μL of each primer in 20 uL. The cycling parameter was as follows: an initial denaturation with 94 °C/1 min followed by 33 cycles of 98 °C/10 s, 63 °C/30 s, and 68 °C/90 s.

2.3. PCR Amplification of DLA-DRB1 Gene

Polymorphism analysis for DLA-DRB1 was performed using RNA samples from the 403 dogs as templates by using DLA-DRB1 specific primer sets (DRB1-F and DRB1-R) (Supplementary Table S1D) [31]. The cDNA samples were synthesized with the oligo-dT primer using the RevaTra Ace reverse transcriptase reaction (TOYOBO, Osaka, Japan) after DNase I treatment using 1 μg of RNA (Invitrogen/Life Technologies/Thermo Fisher Scientific, Carlsbad, CA, USA) according to the manufacturer’s protocol. The polymorphism analysis was also performed using DNA samples from the 426 dogs as templates by using DLA-DRB1 specific primer sets (DRB1-g-F and DRB1-g-R) (Supplementary Table S1E) [32]. The composition of the PCR solution consisted of 20 ng of cDNA or genomic DNA, 0.4 units of KOD FX DNA polymerase, 10 uL of 2× PCR buffer, 2 mM of dNTP, and 0.4 uM of each primer in 20 uL. The cycling parameter was as follows: an initial denaturation with 94 °C/1 min followed by 33 cycles of 98 °C/10 s, 60 °C/30 s, and 68 °C/45 s.

2.4. Sanger-Sequencing

After purification of PCR products using ExoSAP-IT (GE Healthcare, Piscataway, NJ, USA), the purified PCR products were sequenced directly with Big Dye Terminator Kit Ver. 1.1 or Ver. 3.1 (Life Technologies/Thermo Fisher Scientific, Carlsbad, CA, USA) and ABI3130 genetic analyzer (Life Technologies/Thermo Fisher Scientific, Carlsbad, CA, USA). The nucleotide sequences of the PCR products for DLA-88, DLA-12, and DLA-88L were determined using sequencing primers i1F-T and i3R-T (Supplementary Table S1C). When the DLA-88 allele sequences were difficult to determine due to sequence offsets by nucleotide insertions and deletions in intron 2 and/or exon 3 of the DLA-88 alleles [30,33], additional sequencing was performed using another primer i2F2 (Figure 1B).

2.5. Allele Assignment and Confirmation of Novel DLA Alleles

DLA allelic sequences were assigned using Sequencher Ver. 5.0.1 DNA sequence assembly software (Gene Code Co., Ann Arbor, MI, USA) by comparing them with known DLA-88, DLA-88L, DLA-12, and DLA-DRB1 allele sequences released in the GenBank (https://www.ncbi.nlm.nih.gov/genbank/ (accessed on 26 April 2022)) and the IPD-MHC Canines database (https://www.ebi.ac.uk/ipd/mhc/group/DLA/ (accessed on 26 April 2022)). Allele sequences from the Sanger sequencing data also were assigned using the MHC allele assignment software Assign ATF ver. 1.0.2.45 (Conexio, Western Australia, Australia). New alleles were confirmed by PCR and direct sequencing again. The PCR products were cloned into the pTA2 cloning vector with the TA cloning kit (TOYOBO, Osaka, Japan), and the nucleotide sequence in 4 to 8 clones per DNA sample was analyzed to avoid PCR and sequencing artifacts.

2.6. Nomenclature of Novel DLA Alleles

We defined the alleles amplified by using the DLA-88 and DLA-88L specific primer set as the DLA-88L allele and the alleles amplified by using the DLA-12 specific primer set as DLA-12 allele in the 2nd PCR of DLA-12/88L. Since all the DLA-88L alleles reported so far in the IPD-MHC Canines database have been named “DLA-88*”, we also followed the rule for the identified DLA-88L novel alleles as well as all published DLA-88 alleles. The official name of the novel allele was assigned according to the DLA nomenclature in the IPD-MHC database. Novel DLA alleles that have not been given an official allele name were named “DLA-88*nov”, “DLA-12*nov”, or “DLA-DRB1*nov” as tentative allele names.

2.7. Estimation of DLA-88–DLA-12/88L–DLA-DRB1 (88-12/88L-DRB1) Haplotypes

The 88-12/88L-DRB1 haplotypes for each dog, which are 88-12-DRB1 or 88-88L-DRB1, were identified and estimated manually based on genotyping data of 829 dogs as previously described [18,20]. We initially identified the 88-12/88L-DRB1 haplotypes for homozygous dogs and estimated the haplotypes for heterozygous dogs on the basis of those within the homozygous dogs. To confirm our manual haplotype estimation, we also estimated the 88-12/88L-DRB1 haplotypes in each breed by using the maximum likelihood method of the PHASE program [34].

2.8. Data Analysis

Calculation of expected heterozygosity (He), Hardy–Weinberg equilibrium (HWE) test, and principal component analysis (PCA) based on the 88-12/88L-DRB1 haplotype frequencies in each breed were performed by GenAlEx Ver. 6.5 [35]. In the PCA, to reduce the 88-12/88L-DRB1 haplotype numbers as explanatory variables, we used the haplotype frequencies composed of the field-1 level alleles. This level reflects differences in immuno-responsiveness due to changes in the amino acid sequences of the peptide-binding region and T-cell recognition region of each DLA allele [33]. The inbreeding coefficient (Fis) and haplotype richness (Hr) were calculated by FSTAT Ver. 2.9.4 (available from https://www2.unil.ch/popgen/softwares/fstat.htm (accessed on 21 June 2021). In this case, the significant deviation of FIS from zero was also tested by FSTAT Ver. 2.9.4. Pearson product-moment correlation coefficient was calculated with R ver. 3.6.3 (available from https://www.r-project.org/ (accessed on 17 March 2020)) to evaluate differences in DLA-DRB1 allele diversity in the same dog breeds from different countries, UK and Japan. A phylogenetic tree was constructed by the Neighbor Joining method and assessed using 10,000 bootstrap replicates after aligning the DLA sequences using the MEGA X software (available from https://www.megasoftware.net/ (accessed on 3 March 2020) [36]. A pairwise sequence similarity plot was displayed by a graphical user interface GenomeMatcher [37].

3. Results

3.1. Allele Number and Frequency of DLA-88, DLA-88L, DLA-12, and DLA-DRB1

Table 2 and Supplementary Table S2 show detailed information on the types, numbers, and frequencies of DLA-88, DLA-88L, DLA-12, and DLA-DRB1 alleles identified in the 829 dogs. In total, 193 DLA alleles (89 in DLA-88, 18 in DLA-88L, 25 in DLA-12, and 61 in DLA-DRB1) were identified, and 17, 7, 5, and 6 were novel alleles of DLA-88, DLA-88L, DLA-12, and DLA-DRB1, respectively. Figure 2 shows frequencies of the 20 most frequent DLA alleles and the number of animals carrying the alleles in popular breeds in Japan. The highest frequent alleles in each DLA gene were DLA-88*006:01 (allele frequency: 8.9%), DLA-12*001:01:01 (45.1%), and DLA-DRB1*015:01 (14.0%). Although 43 DLA-12/88L alleles were identified, 65.7% (545 dogs) carried DLA-12*001:01:01. In the DLA-DRB1 gene, DLA-DRB1*015 group alleles (DLA-DRB1*015:01, DLA-DRB1*015:02, DLA-DRB1*015:03, and DLA-DRB1*015:04) were the most common, and 37.7% had the alleles. This result showed a similar ratio (23.6%) to the previously published report [20].

3.2. Phylogenetic Relationships of the DLA-88, DLA-88L, and DLA-12 Alleles

A phylogenetic tree of 109 different alleles was reconstructed using the DLA-88, DLA-12, and DLA-88L nucleotide sequences of exon 2–intron 2–exon 3 without indels (746 bp: alignment length). Ninety-nine of the 109 alleles were identified in the 426 dogs that we sequenced in this study. Another 10 DLA-88 nucleotide sequences of exon 2–intron 2–exon 3 were obtained from the IPD-MHC and NCBI databases, and seven (DLA-88*028:04, DLA-88*032:02, DLA-88*045:02, DLA-88*046:01, DLA-88*047:01, DLA-88*049:01 and DLA-88*050:01) were not detected in our study. The phylogenetic tree clearly divided the DLA-88 and DLA-12 alleles into two lineages, and 16 of the 17 DLA-88L alleles were included in the DLA-88 lineage (Figure 3A). The phylogenetic tree clearly divided the DLA-88 and DLA-12 alleles into two lineages, and 16 of the 17 DLA-88L alleles were included in the DLA-88 lineage (Figure 3A). Of the 17 DLA-88L alleles, 14 were composed of two separate lineages containing two common alleles, DLA-88*017:01 and DLA-88*029:01 (Supplementary Table S2). In contrast, DLA-88*nov65, which was assigned as a DLA-88L allele, aligned with the DLA-12 lineage, and its nucleotide sequence showed a high similarity of 99.87% to DLA-12*004:01 (Figure 3B). The intron 2 sequence of DLA-88*nov65 was highly different from DLA-88*501:01 and DLA-88*017:01, which grouped with the DLA-88 and DLA-88L alleles, respect ively (Figure 3B).

3.3. Evaluation of DLA-DRB1 Polymorphisms between Same Dog Breeds in Japan and the United Kingdom

The migration or transportation of dog breeds between different geographic locations has been shown to have a detectable effect on breed structures with the generation of genetically differentiated sub-populations [38,39,40]. Therefore, to evaluate the genetic bias of the DLA polymorphisms between the same dog breeds in Japan and another country, we compared our DLA-DRB1 genotyping data with the previously published DLA-DRB1 polymorphism data in the United Kingdom (UK) [21]. We compared the proportion of the dogs with each of the different DLA-DRB1 alleles in 10 breeds that had been analyzed in more than 12 dogs per breed in the present (Japan) and previous studies (UK). Of the 10 breeds in the UK and Japan, moderate to strong correlations with correlation coefficients ranging from 0.453 (Beagle) to 0.977 (Cavalier King Charles Spaniel), and a median value of 0.853 was confirmed in the nine breeds (Beagle, Golden Retriever, Labrador Retriever, Dachshund, Miniature Schnauzer, American Cocker Spaniel, Cavalier King Charles Spaniel, Shih Tzu, and Yorkshire Terrier) (Figure 4). The Beagles showed a moderate correlation coefficient, but a large difference was observed between the two countries in the proportion of individuals carrying DLA-DRB1*006:01 (74.6% in the UK vs. 10.8% in Japan). However, for Border Collies, whereas 7 out of 10 alleles were commonly observed in both countries, the DLA-DRB1 allele frequency differed markedly, and no positive correlation was observed between the proportions (correlation coefficient r: −0.159) of alleles in each country.

3.4. Frequency of the 88-12/88L-DRB1 Haplotypes

To identify the two 88-12/88L-DRB1 haplotypes (88-12-DRB1 or 88-88L-DRB1) within the 829 dogs, we searched homozygous dogs with the three-loci, any two-loci (88-12/88L, 88-DRB1 and 12/88L-DRB1) and one-locus from our genotyping data. Firstly, 52 different sub-haplotypes of the 88-12/88L-DRB1 haplotypes were identified within 198 dogs (23.8%) that were homozygous at the three loci. Then, 54 sub-haplotypes of the 88-12/88L-DRB1 haplotypes were identified within 40 dogs and 163 dogs that were homozygous at two-loci (88-12/88L in 7 dogs, 88-DRB1 in 7 dogs, 12/88L-DRB1 in 16 dogs) and at one-locus (DLA-88 in 3 dogs, DLA-12/88L in 111 dogs, and DLA-DRB1 in 49 dogs), respectively.
In total, 106 sub-haplotypes of the 88-12/88L-DRB1 haplotypes were identified. In addition, 84 sub-haplotypes of 88-12/88L-DRB1 were estimated from the haplotype estimation of the 428 remaining heterozygous dogs with reference to the 106 sub-haplotypes of the 88-12/88L-DRB1 haplotypes. Consequently, 190 88-12/88L-DRB1 sub-haplotypes in total were obtained from 803 dogs of 49 breeds (Supplementary Table S3). However, the remaining 26 dogs could not be assigned to the 88-12/88L-DRB1 haplotypes, because the combination of sub-haplotypes was not narrowed down to less than three loci. Of 190 88-12/88L-DRB1 sub-haplotypes, 131 were detected two or more times, while the other 59 sub-haplotypes were detected just once within heterozygous dogs (Supplementary Table S3B). The frequencies of 131 sub-haplotypes within the 88-12-DRB1 and the 88-88L-DRB1 haplotype structures were 79.4% and 20.6%, respectively (Table 3).
Of the 131 different 88-12/88L-DRB1 haplotypes, 29 were high-frequency haplotypes with a frequency of 1.0% or more (i.e., the detected number of the haplotype was ≥16) (Table 4). Of these 29 highly frequent haplotypes, four haplotypes (DLA-88*006:01–DLA-12*001:01–DRB1*056:01 (Haplotype(Hp)-ID 116), DLA-88*502:01–DLA-12*001:01–DRB1*001:02 (Hp-ID 6), DLA-88*001:03–DLA-12*001:01–DRB1*046:01 (Hp-ID 91), and DLA-88*511:01–DLA-12*001:03–DRB1*092:01:1 (Hp-ID 117) were observed in only one breed. The other 25 haplotypes were observed in two or more breeds, and 11 sub-haplotypes (Hp-IDs 2, 20, 22, 23, 37, 46, 51, 52, 69, 73, and 99) showed high haplotype frequencies of 70% or more in specific dog breeds (Table 4). Therefore, more than 50% of the high-frequency 88-12/88L-DRB1 haplotypes (15 of 29 haplotypes) were found in breeds with a large number of dogs tested. DLA-88*004:02–DLA-12*001:01–DRB1*006:01 (Hp-ID 12) was detected as the most frequent haplotype in two breeds, Pomeranian (haplotype frequency: 46.6%) and Yorkshire Terrier (Hp frequency: 31.7%) (Supplementary Table S3A). In addition, the DLA-88*003:02–DLA-88*017:01–DRB1*009:01 (Hp-ID 31), and DLA-88*501:01–DLA-12*001:01:01–DRB1*001:01 (Hp-ID 8) were commonly observed in multiple breeds with relatively similar frequencies (Supplementary Table S3A).

3.5. Comparison of Genetic Diversity between Dog Breeds by Haplotype Numbers and Heterozygosity

We investigated the genetic diversity of the 88-12/88L-DRB1 haplotypes using a total of 725 dogs within 24 different dog breeds (analyzed using ≥ 10 dogs/breed) and mongrels (mixed breeds). The number of different haplotypes in each breed ranged from three Shetland Sheepdogs to 27 Toy Poodles (Table 5), and up to 34 different haplotypes among the mongrels (Figure 2). Six dog breeds (Miniature Schnauzer, Shetland Sheepdog, Shiba, American Cocker Spaniel, Papillon, and Bernese Mountain Dog) had one particular 88-12/88L-DRB1 sub-haplotype at a frequency of greater than 50% (Figure 5). Only two or three haplotypes represented more than 80% of all the haplotypes in seven breeds (Miniature Schnauzer, Shetland Sheepdog, Shiba, American Cocker Spaniel, Golden Retriever, Miniature Pinscher, and Shih Tzu). In contrast, more than 20 different haplotypes were detected in Chihuahua and Toy Poodle, and each haplotype frequency was distributed similarly (Figure 5).
We calculated the genetic diversity indices, such as observed heterozygosity (Ho), expected heterozygosity (He), inbreeding coefficient (Fis), and haplotype richness (Hr) to evaluate the 88-12/88L-DRB1 diversity in each breed (Table 5). The mean Ho value in the 24 dog breeds was 0.736. The Ho values deviated significantly from HWE in 8 breeds (Cavalier King Charles Spaniel, Golden Retriever, Labrador Retriever, American Cocker Spaniel, Shiba, Papillon, Shih Tzu, and Beagle), and the Ho values were significantly lower than He values in five breeds (American Cocker Spaniel, Shiba, Papillon, Shih Tzu, and Beagle). The Hr values in the 24 breeds ranged from 2.13 in Shetland Sheepdog to 7.79 in Toy Poodle.

3.6. Characteristics of Genetic Relationship of the 88-12/88L-DRB1 Haplotypes by Principal Component Analysis

To evaluate genetic relationship of the 88-12/88L-DRB1 haplotypes among different dog breeds, PCA was performed using the 24 breeds listed in Table 5. Of the 24 breeds plotted by PCA, 22 breeds were distributed closely around the centroid of the quadrants as if they were almost one population. The Shetland Sheepdog and Miniature Schnauzer breeds diverged markedly from the other 22 breeds. (Figure 6A and Supplementary Table S3A). The positions of the Shetland Sheepdog and Miniature Schnauzer breeds within the matrix appear to have reflected the presence of their dominant haplotypes, 88*003–88*017–DRB1*002 (Hp-ID 20) in Shetland Sheepdog (Hp frequency: 67.1%) and 88*013–12*003–DRB1*009 (Hp-ID 23) in Miniature Schnauzer (68.8%). Since the 88*003–88*017–DRB1*002 (Hp-ID 20) also were commonly observed among Welsh Corgi and Border Collie, these two breeds were located slightly outside the large group of the other breeds and closer to Shetland Sheepdog. Removing the Shetland Sheepdog and Miniature Schnauzer outliers from the PCA analysis changed the genetic relationship slightly between some of the 22 breeds on the basis of the 88-12/88L-DRB1 haplotype frequencies (Figure 6B). For example, the French Bulldog, Bulldog, Border Collie, and Yorkshire Terrier share the 88*028–88*029–DRB1*015 (Hp-IDs 24 and 25) at relatively high frequencies (13.4% to 43.4%), and these four breeds grouped more closely together and at some distance from the other breeds. Similarly, the Golden retriever and Labrador retriever, sharing the 88*508–12*001–DRB1*012 (Hp-ID 21), and American Cocker Spaniel and Cavalier King Charles Spaniel, sharing the 88*003–88*017–DRB1*009 (Hp-ID 31) separated further from each other and at a greater distance from the centroid (0, 0) of the PCA plot (Figure 6B).

3.7. Number of Potential Recipients for 88-12/88L-DRB1-Matched Transplantation, Assuming Homozygous-Derived Somatic Stem Cells as Donors

Assuming that somatic stem cells could be established from the 52 types of homozygotes of the 88-12/88L-DRB1 haplotypes and that these cells could be used as donors for 88-12/88L-DRB1-matched transplantations, we statistically modeled the number of dogs that might be recipients from the 829 individuals analyzed in this study (Figure 7). From our statistical simulation, if donor cells are established from 9, 28, and 52 types of high frequency 88-12/88L-DRB1 homozygotes, 411 (51.2%), 650 (80.7%), and 733 (90.9%) dogs might be considered eligible for 88-12/88L-DRB1-matched transplantation as recipients. Furthermore, in 17 of 24 dog breeds (70.8%) listed in Table 5, 50% or more of these dogs might benefit from the 88-12/88L-DRB1-matched transplantation by using donor dogs with the most frequent 88-12/88L-DRB1 haplotypes in each breed (Table 6). Additionally, homozygotes of all haplotypes listed in Table 6, except 88*006:01–DLA-12*001:01–DRB1*015:01 (Hp-ID 37), were detected in the present study (Supplementary Table S3A).

4. Discussion

In this study, we genotyped the DLA-88, DLA-12/88L, and DLA-DRB1 loci by Sanger sequencing using 829 dogs of 59 breeds and identified 89, 43, and 61 alleles, respectively. We also developed a two-stage PCR method for the polymorphism analysis of the DLA-88, DLA-88L, and DLA-12 genes by separating DLA-88 and DLA-12/88L with the 1st PCR and DLA-12 and DLA-88L with the 2nd PCR (Figure 1B). This polymorphism analysis by PCR and sequencing clearly distinguished the DLA-88L allele from the DLA-88 allele, which was difficult with conventional RNA-based methods [15,18]. In fact, the previously reported DLA-88*042:02 [17] belongs to DLA-88L rather than DLA-88, and this allele along with DLA-88*008:02 and DLA-DRB1*004:01 constituted the 88-88L-DRB1 haplotype in the Maltese breed (Supplementary Table S2A). Therefore, this simpler and more accurate two-stage PCR method is an important tool to use for a better understanding of the DLA loci and haplotype differences and for evaluating various immune responses in dogs.
Overall, we identified 29 novel DLA-88, DLA-88L, and DLA-DRB1 alleles in this study. Of them, DLA-88*nov65 was newly detected as a DLA-88L allele that showed a different phylogenetic relationship from other DLA-88L alleles, and was highly similar to DLA-12*004:01 of the DLA-12 lineage (Figure 3). Interestingly, our previous study showed that DLA-12*004:01 was generated by a gene conversion event within the exon 2 region between the DLA-12 and DLA-88 alleles [30]. Therefore, the DLA-88*nov65 also might have been generated by gene conversion between the DLA-88 and DLA-12 alleles, similar to DLA-12*004:01. There may be many other unidentified DLA alleles generated by such gene conversions events.
In contrast to the DLA-I genes, the polymorphisms and diversity analyses of the DLA-II genes (DLA-DRB–DLA-DQA–DLA-DQB) have been performed previously in many different dog breeds [21,22,41,42]. Although the Japanese native species of Shiba has not been well analyzed previously, our current analysis showed that DLA-DRB1*056:01 (allele frequency: 55.4%) was the most frequent allele, followed by DLA-DRB1*092:01:1 (18.9%), and DLA-DRB1*011:03 (16.2%) (Supplementary Table S3A). These DLA-DRB1 alleles were detected only in Shiba, and therefore their detection is extremely rare even in past polymorphism analyses of the DLA-II genes, including other dog breeds of Asian origin [21,42]. The DLA polymorphism information on Japanese native breeds is extremely limited [42,43]. In this study, although we analyzed Japanese native species Shiba, Akita, Japanese Spitz, Chin, and Shikoku, the number of animals analyzed was less than 10 animals except for the 37 in the Shiba breed. Therefore, more DLA allele information is necessary for Japanese native species as well as for dog breeds that have not yet been analyzed.
Recent genomic analysis of the remains of extinct Japanese wolves (Canis lupus hodophilax) showed phylogenetically that after the Japanese wolf and modern dog ancestry had diverged from grey wolf lineages, gene flow occurred from the ancestor of Japanese wolves into the ancestor of Japanese dogs, including Shiba, and this flow likely continued and contributed to differentiate between the lineage of Japanese dogs and West Eurasian dogs [44]. Interestingly, DLA-DRB1*056:01 of Shiba was detected in Finnish and Russian wolves with frequencies of 4.0% and 2.9%, respectively [45], and Shiba DLA-DRB1*092:01:1 was detected in Canadian and Croatian wolves with frequencies of 6.0% and 11.0%, respectively [46,47]. These results indicated that Shiba might be a unique breed that shared some of its genomic sequences, including the DLA genomic region, with its ancestor in a different way than those of the European modern dog breeds.
High homozygosity of the DLA haplotypes generally implies a loss of DLA genetic diversity. The Ho values showed significantly lower values than the He values in 5 dog breeds, American Cocker Spaniel, Shiba, Papillon, Shih Tzu, and Beagle (Table 5). This suggests a high level of inbreeding in these five breeds. The high Fis values also observed in Shih Tzu (0.209) and Papillon (0.171) strongly suggest that the DLA diversity in these breeds of our population sample is decreasing by inbreeding (Table 5). Moreover, Shetland Sheepdog showed an extremely low Ho value of 0.314 (Table 5). The loss of genetic diversity due to high homozygosity might increase the deleterious genetic variation in pure-breed dogs [48]. Also, high homozygosity of the DLA region due to both inbreeding and genetic bottlenecks by selective artificial breeding was associated with the development of autoimmune diseases in Italian Greyhounds [49]. In contrast, MHC heterogeneity of the Sea lion in wild populations appears advantageous to protect against infectious diseases [50], whereas the pregnancy rate in horses was reported to be decreased by sharing common MHC types between males and females [51]. Therefore, loss of the DLA diversity may affect biological fitness as homozygosity progresses.
The homozygous rate of DLA-DRB1–DLA-DQA1–DLA-DQB1 haplotypes was 35% in a previous study [22]. These three DLA-II genes are located together within 100 kb, while DLA-88 is located far from DLA-DRB1 by over 1.0 Mb [13], resulting in a much stronger linkage disequilibrium (LD) within the DLA-DRB1–DLA-DQA1–DLA-DQB1 haplotype than the 88-12/88L-DRB1 haplotype. Therefore, the lower 88-12/88L-DRB1 homozygous rate (23.8%) in this study than that of DLA-DRB1–DLA-DQA1–DLA-DQB1 haplotype in the previous study [22] might be associated with LD and rates of recombination between different DLA gene loci. The detection of 52 types of homozygotes for the 88-12/88L-DRB1 haplotypes suggests that 90.9% of the dogs analyzed in our study would have a successful 88-12/88L-DRB1-matched transplantation if their somatic stem cells were used in such a procedure. In comparison, if induced pluripotent stem cells (iPSCs) were established from homozygotes of 30 and 50 types of HLA haplotypes (HLA-A–HLA-B–HLA-DRB1) that are frequently observed in Japanese, 82.2% and 90.7% of Japanese would benefit from HLA-matched iPSC transplantation [52]. However, the HLA homozygosity rate for humans is relatively low at 0.5 to 1.5% for the HLA-A–HLA-B–HLA-DRB1 haplotype [53,54,55]. Therefore, the HLA of 15,000 and 24,000 individuals would need to be genotyped to identify these 30 and 50 HLA homozygotes, respectively [52]. In this regard, the MHC homozygotes, preferred donors for somatic stem cell sources, would be much easier to detect in dogs than in humans due to their higher rate of MHC homozygosity. Moreover, our new data on the frequency of DLA haplotypes in various dog breeds could help in the implementation of somatic stem cell transplantation along with a recent development of clinical-grade canine iPSCs derivation [56,57] and assist with the high expectations for regenerative medicine in the veterinary field [58].
In the PCA using the 88-12/88L-DRB1 haplotype frequencies, the values of the first principal component (PC1) and the second principal component (PC2) were extremely low at around 10% in both analyses, but with relatively strong diversity between the DLA haplotypes among the 24 dog breeds, which are popular in Japan (Figure 6). The Hr values of 88-12/88L-DRB1 were less than five in 11 breeds, suggesting that there were relatively few breeds with many different types of 88-12/88L-DRB1 haplotypes (Table 5). Moreover, haplotype frequency bias was confirmed for six breeds, with some haplotype frequencies at 50% or more within each breed (Figure 5). These results showed that the DLA diversity is highly conserved within most breeds, but divergent between almost all breeds, as similarly observed in a previous study on the DLA-II haplotype diversity [20,22]. Therefore, the DLA allele and DLA haplotype frequencies appear to change largely depending on the breeds. Of the 829 dogs of 59 breeds analyzed in this study, 68.5% (568 of 829 dogs) were from the top 20 most popular breeds registered in Japan (Table 1). In contrast, only a few dogs were analyzed from breeds that are listed in the top ten most popular breeds in the USA (American Kennel Club; https://www.akc.org/ (accessed on 28 November 2022)), such as German Shepherd and Rottweiler, which were less popular breeds in Japan. The genetic closeness of the DLA haplotypes among different breeds can be evaluated more accurately by enhancing the DLA genotyping data of breeds from which only a small number of dogs were analyzed in our present study. We showed that there are differences in the distribution of DLA-DRB1 alleles within the same breeds, such as Border Collie and Beagle, particularly if they are located in different countries, such as Japan and the UK (Figure 4). Since differences in the DLA diversity within a single breed between different countries have also been reported in some other breeds [49,59,60], geographical location can affect DLA diversity resulting in differences in the susceptibility for various diseases even in a single breed between different countries. From such a discussion, further DLA polymorphisms analysis for various breeds in different countries is warranted to better comprehend the intriguing features of DLA diversity.
A limitation of our study concerning DLA haplotypes containing both DLA-I and DLA-II genes was not to include DLA-DQA1 and DLA-DQB1 polymorphisms that might be linked to the 88-12/88L-DRB1 haplotypes. This was beyond the scope of our present study. The three genes of DLA-DRB1, DLA-DQA1, and DLA-DQB1 often show strong linkage disequilibrium [22], but novel DLA-DRB1–DLA-DQA1–DLA-DQB1 haplotypes might be generated by the recombination between the DLA-DR and DLA-DQ genes. Although the mismatch of HLA-DQ polymorphisms in organ transplantation is associated with the production of de novo donor-specific antibodies (DSA) against the HLA-DQ molecules and contributes to poor graft outcomes [61,62], such studies are lacking in dogs. Therefore, in regard to transplantations in dogs, further studies are necessary to genotype DLA-DQA1 and DLA-DQB1 and consolidate the extended haplotypes that were identified in our study, including all DLA-I and DLA-II genes, to select the most suitable organ donors in future.
Several specific DLA-II alleles and haplotypes have been reported so far to associate with various diseases in different breeds. For example, DLA-DRB1*010:01:1 or the DLA-DRB1*010:01:1–DLA-DQA1*002:01–DLA-DQB1*015:01 haplotype is associated significantly with the risk of necrotizing meningoencephalitis in Pug [63]. DLA-DRB1*094:01 is associated significantly with acquired retinal degradation syndrome in Dachshunds [64]. These susceptible DLA-DRB1 alleles were also detected in the Pugs and Dachshunds in our study (Supplementary Table S3A). However, the association between the DLA alleles and diseases is unknown because we did not survey the medical history of the individuals used in this study. Also, we have not evaluated the association between decreased heterozygosity of the DLA haplotype and decreased biological fitness. Considering these limitations of the present study, we would like to elucidate the association between DLA polymorphisms and diseases and fertility in the future by investigating the disease history in each of the major breeds in our study population.

5. Conclusions

The genetic diversity of DLA haplotypes varied remarkably between breeds but was relatively conserved within the breed in our large-scale polymorphism analysis. The genetic characteristics of the high DLA homozygosity rate and poor DLA diversity within the same breed are useful for transplantation therapy, but they also may affect biological fitness negatively as homozygosity progresses. This DLA polymorphism information might be useful in future studies for the realization of canine transplantation medicine and elucidation of the pathology of various diseases and for the development of DLA-haplotype-based veterinary medicine.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/cells12050809/s1, Supplementary Table S1: Information on primers using this study; Supplementary Table S2: Detailed information on each allele detected in this study; Supplementary Table S3: Summary of estimated the 88-12/88L-DRB1 haplotypes of 803 dogs with 49 breeds and mongrels.

Author Contributions

Conceptualization, J.M., T.M. and T.S.; data curation, J.M.; formal analysis, J.M.; funding acquisition, F.K. and T.M.; investigation, J.M. and M.O.; methodology, J.M. and T.S.; project administration, J.M., T.M. and T.S.; resources, J.M., M.O. and T.M.; supervision, T.M. and T.S. validation, J.M.; visualization, J.M. writing—original draft, J.M.; writing—review and editing, F.K., J.K.K., T.M. and T.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a grant of International joint research and training of young researchers for zoonosis control in the globalized world (S1491007) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan and also was funded by Lumirize Inc.

Institutional Review Board Statement

The study design and protocol were approved by the Ethics Committee of the Animal Medical Center of Nihon University (#3-027, 1 November 2022) for studies involving humans. All blood samples were collected from the Animal Medical Center (ANMEC) at Nihon University, the Marble Veterinary Medical center, and the Nippon Veterinary and Life Science University in accordance with the guidelines for animal experiments specific to each location when the dog owner approved to use the blood for research.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank Toshihiro Watari, Tomohiro Nakayama, Daisuke Ito, and Mamiko Seki at the Animal Medical Center (ANMEC) at Nihon University, Shinichi Namba at the Marble Veterinary Medical center (Fujisawa, Japan), and Kozo Ohkusu-Tsukada at the Nippon Veterinary and Life Science University for providing the dog blood samples. We also thank Sayaka Ito at the Department of Molecular Life Science in the Tokai University School of Medicine for technical assistance.

Conflicts of Interest

The authors declare no conflict of interest.

Nomenclature

Haplotype(s)A set of closely linked alleles on a chromosome carrying the three-gene loci combination of 88-12-DRB1 or 88-88L-DRB1 and represented by 88-12/88L-DRB1 where 12/88L could be either 12 or 88L.
Sub-haplotype(s)A single locus (88, 12, 88L, 12/88L, DRB1) or two-locus subtype (88-12/88L, 88/DRB1, 12/88L-DRB1) of the three locus-haplotype 88-12/88L-DRB1.
Homozygous haplotypesTwo identical haplotypes in diploid cells.
Heterozygous haplotypesTwo different haplotypes in diploid cells.
MongrelsMixtures of different pure dog breeds or interbreeds.

References

  1. König, R.; Huang, L.-Y.; Germain, R.N. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 1992, 356, 796–798. [Google Scholar] [CrossRef] [PubMed]
  2. Garcia, K.C.; Scott, C.A.; Brunmark, A.; Carbone, F.R.; Peterson, P.A.; Wilson, I.A.; Teyton, L. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 1996, 384, 577–581. [Google Scholar] [CrossRef] [PubMed]
  3. Shiina, T.; Inoko, H.; Kulski, J. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004, 64, 631–649. [Google Scholar] [CrossRef]
  4. Shiina, T.; Hosomichi, K.; Inoko, H.; Kulski, J.K. The HLA genomic loci map: Expression, interaction, diversity and disease. J. Hum. Genet. 2009, 54, 15–39. [Google Scholar] [CrossRef]
  5. Matzaraki, V.; Kumar, V.; Wijmenga, C.; Zhernakova, A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 2017, 18, 76. [Google Scholar] [CrossRef] [PubMed]
  6. Montgomery, R.A.; Tatapudi, V.S.; Leffell, M.S.; Zachary, A.A. HLA in transplantation. Nat. Rev. Nephrol. 2018, 14, 558–570. [Google Scholar] [CrossRef]
  7. Eapen, M.; Klein, J.P.; Sanz, G.F.; Spellman, S.; Ruggeri, A.; Anasetti, C.; Brown, M.; Champlin, R.E.; Garcia-Lopez, J.; Hattersely, G. Effect of donor–recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: A retrospective analysis. Lancet Oncol. 2011, 12, 1214–1221. [Google Scholar] [CrossRef]
  8. Zachary, A.A.; Leffell, M.S. HLA mismatching strategies for solid organ transplantation–a balancing act. Front. Immunol. 2016, 7, 575. [Google Scholar] [CrossRef]
  9. Sugita, S.; Iwasaki, Y.; Makabe, K.; Kimura, T.; Futagami, T.; Suegami, S.; Takahashi, M. Lack of T cell response to iPSC-derived retinal pigment epithelial cells from HLA homozygous donors. Stem Cell Rep. 2016, 7, 619–634. [Google Scholar] [CrossRef]
  10. Schoenebeck, J.J.; Ostrander, E.A. Insights into morphology and disease from the dog genome project. Annu. Rev. Cell Dev. Biol. 2014, 30, 535–560. [Google Scholar] [CrossRef] [PubMed]
  11. Graves, S.S.; Storb, R. Developments and translational relevance for the canine haematopoietic cell transplantation preclinical model. Vet. Comp. Oncol. 2020, 18, 471–483. [Google Scholar] [CrossRef]
  12. Kirkness, E.F.; Bafna, V.; Halpern, A.L.; Levy, S.; Remington, K.; Rusch, D.B.; Delcher, A.L.; Pop, M.; Wang, W.; Fraser, C.M. The dog genome: Survey sequencing and comparative analysis. Science 2003, 301, 1898–1903. [Google Scholar] [CrossRef] [PubMed]
  13. Lindblad-Toh, K.; Wade, C.M.; Mikkelsen, T.S.; Karlsson, E.K.; Jaffe, D.B.; Kamal, M.; Clamp, M.; Chang, J.L.; Kulbokas, E.J.; Zody, M.C. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 2005, 438, 803–819. [Google Scholar] [CrossRef] [PubMed]
  14. Graumann, M.; DeRose, S.; Ostrander, E.; Storb, R. Polymorphism analysis of four canine MHC class I genes. Tissue Antigens 1998, 51, 374–381. [Google Scholar] [CrossRef] [PubMed]
  15. Ross, P.; Buntzman, A.S.; Vincent, B.G.; Grover, E.N.; Gojanovich, G.S.; Collins, E.J.; Frelinger, J.A.; Hess, P.R. Allelic diversity at the DLA-88 locus in Golden Retriever and Boxer breeds is limited. Tissue Antigens 2012, 80, 175–183. [Google Scholar] [CrossRef]
  16. Venkataraman, G.M.; Geraghty, D.; Fox, J.; Graves, S.S.; Zellmer, E.; Storer, B.E.; Torok-Storb, B.J.; Storb, R. Canine DLA-79 gene: An improved typing method, identification of new alleles and its role in graft rejection and graft-versus-host disease. Tissue Antigens 2013, 81, 204–211. [Google Scholar] [CrossRef]
  17. Venkataraman, G.M.; Kennedy, L.J.; Little, M.T.; Graves, S.S.; Harkey, M.A.; Torok-Storb, B.J.; Storb, R. Thirteen novel canine dog leukocyte antigen-88 alleles identified by sequence-based typing. Hla 2017, 90, 165–170. [Google Scholar] [CrossRef]
  18. Miyamae, J.; Suzuki, S.; Katakura, F.; Uno, S.; Tanaka, M.; Okano, M.; Matsumoto, T.; Kulski, J.K.; Moritomo, T.; Shiina, T. Identification of novel polymorphisms and two distinct haplotype structures in dog leukocyte antigen class I genes: DLA-88, DLA-12 and DLA-64. Immunogenetics 2018, 70, 237–255. [Google Scholar] [CrossRef]
  19. Wagner, J.; DeRose, S.; Burnett, R.; Storb, R. Nucleotide sequence and polymorphism analysis of canine DRA cDNA clones. Tissue Antigens 1995, 45, 284–287. [Google Scholar] [CrossRef]
  20. Kennedy, L.J.; Barnes, A.; Happ, G.; Quinnell, R.; Bennett, D.; Angles, J.; Day, M.; Carmichael, N.; Innes, J.; Isherwood, D. Extensive interbreed, but minimal intrabreed, variation of DLA class II alleles and haplotypes in dogs. Tissue Antigens 2002, 59, 194–204. [Google Scholar] [CrossRef]
  21. Kennedy, L.; Barnes, A.; Short, A.; Brown, J.; Lester, S.; Seddon, J.; Fleeman, L.; Francino, O.; Brkljacic, M.; Knyazev, S. Canine DLA diversity: 1. New alleles and haplotypes. Tissue Antigens 2007, 69, 272–288. [Google Scholar] [CrossRef]
  22. Kennedy, L.J.; Ollier, W.E.; Marti, E.; Wagner, J.L.; Storb, R.F. Canine immunogenetics. In The Genetics of the Dog; CABI: Wallingford, UK, 2012; pp. 91–135. [Google Scholar]
  23. Tsai, K.L.; Starr-Moss, A.N.; Venkataraman, G.M.; Robinson, C.; Kennedy, L.J.; Steiner, J.M.; Clark, L.A. Alleles of the major histocompatibility complex play a role in the pathogenesis of pancreatic acinar atrophy in dogs. Immunogenetics 2013, 65, 501–509. [Google Scholar] [CrossRef]
  24. Hardt, C.; Ferencik, S.; Tak, R.; Hoogerbrugge, P.; Wagner, V.; Grosse-Wilde, H. Sequence-based typing reveals a novel DLA-88 allele, DLA-88* 04501, in a beagle family. Tissue Antigens 2006, 67, 163–165. [Google Scholar] [CrossRef]
  25. Ollier, W.E.; Kennedy, L.J.; Thomson, W.; Barnes, A.N.; Bell, S.C.; Bennett, D.; Angles, J.M.; Innes, J.F.; Carter, S.D. Dog MHC alleles containing the human RA shared epitope confer susceptibility to canine rheumatoid arthritis. Immunogenetics 2001, 53, 669–673. [Google Scholar] [CrossRef] [PubMed]
  26. Kennedy, L.; Barnes, A.; Short, A.; Brown, J.; Seddon, J.; Fleeman, L.; Brkljacic, M.; Happ, G.; Catchpole, B.; Ollier, W. Canine DLA diversity: 3. Disease studies. Tissue Antigens 2007, 69, 292–296. [Google Scholar] [CrossRef]
  27. Denyer, A.; Massey, J.; Davison, L.; Ollier, W.; Catchpole, B.; Kennedy, L. Dog leucocyte antigen (DLA) class II haplotypes and risk of canine diabetes mellitus in specific dog breeds. Canine Med. Genet. 2020, 7, 15. [Google Scholar] [CrossRef] [PubMed]
  28. Nakazawa, M.; Miyamae, J.; Okano, M.; Kanemoto, H.; Katakura, F.; Shiina, T.; Ohno, K.; Tsujimoto, H.; Moritomo, T.; Watari, T. Dog leukocyte antigen (DLA) class II genotypes associated with chronic enteropathy in French bulldogs and miniature dachshunds. Vet. Immunol. Immunopathol. 2021, 237, 110271. [Google Scholar] [CrossRef]
  29. Friedenberg, S.G.; Buhrman, G.; Chdid, L.; Olby, N.J.; Olivry, T.; Guillaumin, J.; O’Toole, T.; Goggs, R.; Kennedy, L.J.; Rose, R.B. Evaluation of a DLA-79 allele associated with multiple immune-mediated diseases in dogs. Immunogenetics 2016, 68, 205–217. [Google Scholar] [CrossRef]
  30. Miyamae, J.; Okano, M.; Nishiya, K.; Katakura, F.; Kulski, J.K.; Moritomo, T.; Shiina, T. Haplotype structures and polymorphisms of dog leukocyte antigen (DLA) class I loci shaped by intralocus and interlocus recombination events. Immunogenetics 2022, 74, 245–259. [Google Scholar] [CrossRef] [PubMed]
  31. Miyamae, J.; Yagi, H.; Sato, K.; Okano, M.; Nishiya, K.; Katakura, F.; Sakai, M.; Nakayama, T.; Moritomo, T.; Shiina, T. Evaluation of alloreactive T cells based on the degree of MHC incompatibility using flow cytometric mixed lymphocyte reaction assay in dogs. Immunogenetics 2019, 71, 635–645. [Google Scholar] [CrossRef]
  32. Wagner, J.; Burnett, R.; Works, J.; Storb, R. Molecular analysis of DLA-DRBB1 polymorphism. Tissue Antigens 1996, 48, 554–561. [Google Scholar] [CrossRef] [PubMed]
  33. Kennedy, L.J.; Angles, J.; Barnes, A.; Carter, S.; Francino, O.; Gerlach, J.; Happ, G.; Ollier, W.; Thomson, W.; Wagner, J. Nomenclature for factors of the dog major histocompatibility system (DLA), 2000: Second report of the ISAG DLA Nomenclature Committee. Anim. Genet. 2001, 32, 193–199. [Google Scholar] [CrossRef]
  34. Stephens, M.; Smith, N.J.; Donnelly, P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68, 978–989. [Google Scholar] [CrossRef]
  35. Peakall, R.; Smouse, P.E. GENALEX 6: Genetic analysis in Excel. Population genetic software for teaching and research. Mol. Ecol. Notes 2006, 6, 288–295. [Google Scholar] [CrossRef]
  36. Kumar, S.; Stecher, G.; Li, M.; Knyaz, C.; Tamura, K. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 2018, 35, 1547–1549. [Google Scholar] [CrossRef]
  37. Ohtsubo, Y.; Ikeda-Ohtsubo, W.; Nagata, Y.; Tsuda, M. GenomeMatcher: A graphical user interface for DNA sequence comparison. BMC Bioinform. 2008, 9, 376. [Google Scholar] [CrossRef]
  38. Quignon, P.; Herbin, L.; Cadieu, E.; Kirkness, E.F.; Hédan, B.; Mosher, D.S.; Galibert, F.; André, C.; Ostrander, E.A.; Hitte, C. Canine population structure: Assessment and impact of intra-breed stratification on SNP-based association studies. PLoS ONE 2007, 2, e1324. [Google Scholar] [CrossRef] [PubMed]
  39. Parker, H.G.; Dreger, D.L.; Rimbault, M.; Davis, B.W.; Mullen, A.B.; Carpintero-Ramirez, G.; Ostrander, E.A. Genomic analyses reveal the influence of geographic origin, migration, and hybridization on modern dog breed development. Cell Rep. 2017, 19, 697–708. [Google Scholar] [CrossRef] [PubMed]
  40. Lampi, S.; Donner, J.; Anderson, H.; Pohjoismäki, J. Variation in breeding practices and geographic isolation drive subpopulation differentiation, contributing to the loss of genetic diversity within dog breed lineages. Canine Med. Genet. 2020, 7, 5. [Google Scholar] [CrossRef]
  41. Runstadler, J.; Angles, J.; Pedersen, N.C. Dog leucocyte antigen class II diversity and relationships among indigenous dogs of the island nations of Indonesia (Bali), Australia and New Guinea. Tissue Antigens 2006, 68, 418–426. [Google Scholar] [CrossRef]
  42. Kang, M.; Ahn, B.; Youk, S.; Cho, H.-s.; Choi, M.; Hong, K.; Do, J.T.; Song, H.; Jiang, H.; Kennedy, L.J. High Allelic Diversity of Dog Leukocyte Antigen Class II in East Asian Dogs: Identification of New Alleles and Haplotypes. J. Mamm. Evol. 2021, 28, 773–784. [Google Scholar] [CrossRef]
  43. Niskanen, A.; Hagström, E.; Lohi, H.; Ruokonen, M.; Esparza-Salas, R.; Aspi, J.; Savolainen, P. MHC variability supports dog domestication from a large number of wolves: High diversity in Asia. Heredity 2013, 110, 80–85. [Google Scholar] [CrossRef] [PubMed]
  44. Gojobori, J.; Arakawa, N.; Xiayire, X.; Matsumoto, Y.; Matsumura, S.; Hongo, H.; Ishiguro, N.; Terai, Y. The Japanese wolf is most closely related to modern dogs and its ancestral genome has been widely inherited by dogs throughout East Eurasia. bioRxiv 2021, 2021, 463851. [Google Scholar]
  45. Niskanen, A.; Kennedy, L.; Ruokonen, M.; Kojola, I.; Lohi, H.; Isomursu, M.; Jansson, E.; Pyhäjärvi, T.; Aspi, J. Balancing selection and heterozygote advantage in major histocompatibility complex loci of the bottlenecked Finnish wolf population. Mol. Ecol. 2014, 23, 875–889. [Google Scholar] [CrossRef]
  46. Arbanasić, H.; Huber, Đ.; Kusak, J.; Gomerčić, T.; Hrenović, J.; Galov, A. Extensive polymorphism and evidence of selection pressure on major histocompatibility complex DLA-DRB1, DQA1 and DQB1 class II genes in Croatian grey wolves. Tissue Antigens 2013, 81, 19–27. [Google Scholar] [CrossRef]
  47. Kennedy, L.J.; Angles, J.M.; Barnes, A.; Carmichael, L.E.; Radford, A.D.; Ollier, W.E.; Happ, G.M. DLA-DRB1, DQA1, and DQB1 alleles and haplotypes in North American gray wolves. J. Hered. 2007, 98, 491–499. [Google Scholar] [CrossRef] [PubMed]
  48. Marsden, C.D.; Ortega-Del Vecchyo, D.; O’Brien, D.P.; Taylor, J.F.; Ramirez, O.; Vilà, C.; Marques-Bonet, T.; Schnabel, R.D.; Wayne, R.K.; Lohmueller, K.E. Bottlenecks and selective sweeps during domestication have increased deleterious genetic variation in dogs. Proc. Natl. Acad. Sci. USA 2016, 113, 152–157. [Google Scholar] [CrossRef] [PubMed]
  49. Pedersen, N.C.; Liu, H.; Leonard, A.; Griffioen, L. A search for genetic diversity among Italian Greyhounds from Continental Europe and the USA and the effect of inbreeding on susceptibility to autoimmune disease. Canine Genet. Epidemiol. 2015, 2, 17. [Google Scholar] [CrossRef] [PubMed]
  50. Osborne, A.J.; Pearson, J.; Negro, S.S.; Chilvers, B.L.; Kennedy, M.A.; Gemmell, N.J. Heterozygote advantage at MHC DRB may influence response to infectious disease epizootics. Mol. Ecol. 2015, 24, 1419–1432. [Google Scholar] [CrossRef]
  51. Burger, D.; Thomas, S.; Aepli, H.; Dreyer, M.; Fabre, G.; Marti, E.; Sieme, H.; Robinson, M.R.; Wedekind, C. Major histocompatibility complex-linked social signalling affects female fertility. Proc. R. Soc. B Biol. Sci. 2017, 284, 20171824. [Google Scholar] [CrossRef]
  52. Nakatsuji, N.; Nakajima, F.; Tokunaga, K. HLA-haplotype banking and iPS cells. Nat. Biotechnol. 2008, 26, 739–740. [Google Scholar] [CrossRef]
  53. Taylor, C.J.; Bolton, E.M.; Pocock, S.; Sharples, L.D.; Pedersen, R.A.; Bradley, J.A. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 2005, 366, 2019–2025. [Google Scholar] [CrossRef]
  54. Lin, G.; Xie, Y.; OuYang, Q.; Qian, X.; Xie, P.; Zhou, X.; Xiong, B.; Tan, Y.; Li, W.; Deng, L. HLA-matching potential of an established human embryonic stem cell bank in China. Cell Stem Cell 2009, 5, 461–465. [Google Scholar] [CrossRef] [PubMed]
  55. Álvarez-Palomo, B.; García-Martinez, I.; Gayoso, J.; Raya, A.; Veiga, A.; Abad, M.L.; Eiras, A.; Guzmán-Fulgencio, M.; Luis-Hidalgo, M.; Eguizabal, C. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells. Stem Cell Res. Ther. 2021, 12, 233. [Google Scholar] [CrossRef] [PubMed]
  56. Kimura, K.; Tsukamoto, M.; Tanaka, M.; Kuwamura, M.; Ohtaka, M.; Nishimura, K.; Nakanishi, M.; Sugiura, K.; Hatoya, S. Efficient reprogramming of canine peripheral blood mononuclear cells into induced pluripotent stem cells. Stem Cells Dev. 2021, 30, 79–90. [Google Scholar] [CrossRef] [PubMed]
  57. Yoshimatsu, S.; Edamura, K.; Yoshii, Y.; Iguchi, A.; Kondo, H.; Shibuya, H.; Sato, T.; Shiozawa, S.; Okano, H. Non-viral derivation of a transgene-free induced pluripotent stem cell line from a male beagle dog. Stem Cell Res. 2021, 53, 102375. [Google Scholar] [CrossRef]
  58. Scarfone, R.A.; Pena, S.M.; Russell, K.A.; Betts, D.H.; Koch, T.G. The use of induced pluripotent stem cells in domestic animals: A narrative review. BMC Vet. Res. 2020, 16, 477. [Google Scholar] [CrossRef]
  59. Angles, J.; Kennedy, L.; Pedersen, N.C. Frequency and distribution of alleles of canine MHC-II DLA-DQB1, DLA-DQA1 and DLA-DRB1 in 25 representative American Kennel Club breeds. Tissue Antigens 2005, 66, 173–184. [Google Scholar] [CrossRef]
  60. Gershony, L.C.; Belanger, J.M.; Short, A.D.; Le, M.; Hytönen, M.K.; Lohi, H.; Famula, T.R.; Kennedy, L.J.; Oberbauer, A.M. DLA class II risk haplotypes for autoimmune diseases in the bearded collie offer insight to autoimmunity signatures across dog breeds. Canine Genet. Epidemiol. 2019, 6, 2. [Google Scholar] [CrossRef]
  61. DeVos, J.M.; Gaber, A.O.; Knight, R.J.; Land, G.A.; Suki, W.N.; Gaber, L.W.; Patel, S.J. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation. Kidney Int. 2012, 82, 598–604. [Google Scholar] [CrossRef]
  62. Tikkanen, J.M.; Singer, L.G.; Kim, S.J.; Li, Y.; Binnie, M.; Chaparro, C.; Chow, C.-W.; Martinu, T.; Azad, S.; Keshavjee, S.; et al. De novo DQ donor-specific antibodies are associated with chronic lung allograft dysfunction after lung transplantation. Am. J. Respir. Crit. Care Med. 2016, 194, 596–606. [Google Scholar] [CrossRef] [PubMed]
  63. Greer, K.; Wong, A.; Liu, H.; Famula, T.; Pedersen, N.C.; Ruhe, A.; Wallace, M.; Neff, M. Necrotizing meningoencephalitis of Pug dogs associates with dog leukocyte antigen class II and resembles acute variant forms of multiple sclerosis. Tissue Antigens 2010, 76, 110–118. [Google Scholar] [CrossRef] [PubMed]
  64. Stromberg, S.J.; Thomasy, S.M.; Marangakis, A.D.; Kim, S.; Cooper, A.E.; Brown, E.A.; Maggs, D.J.; Bannasch, D.L. Evaluation of the major histocompatibility complex (MHC) class II as a candidate for sudden acquired retinal degeneration syndrome (SARDS) in Dachshunds. Vet. Ophthalmol. 2019, 22, 751–759. [Google Scholar] [CrossRef] [PubMed]
Cells 12 00809 g001
Figure 1. Schematic representations of haplotype structures and typing method for DLA-I genes. (A) Two different haplotype structures associated with DLA-12 and DLA-88L locus. Interlocus gene conversion events in cis or trans between DLA-88 and DLA-12 are likely to be responsible for generating the DLA-88L locus. (B) Flow chart for locus-specific DLA typing method for DLA-88, DLA-12, and DLA-88L genes with genomic DNA. White and black-filled boxes in the chart represent the schematic location of UTR and CDS regions of a DLA gene. Arrowheads indicate the location and direction of the primers with the primer names whose detailed information is described in Supplementary Table S1.
Figure 1. Schematic representations of haplotype structures and typing method for DLA-I genes. (A) Two different haplotype structures associated with DLA-12 and DLA-88L locus. Interlocus gene conversion events in cis or trans between DLA-88 and DLA-12 are likely to be responsible for generating the DLA-88L locus. (B) Flow chart for locus-specific DLA typing method for DLA-88, DLA-12, and DLA-88L genes with genomic DNA. White and black-filled boxes in the chart represent the schematic location of UTR and CDS regions of a DLA gene. Arrowheads indicate the location and direction of the primers with the primer names whose detailed information is described in Supplementary Table S1.
Cells 12 00809 g001
Cells 12 00809 g002
Figure 2. Top 20, 21 or 22 most frequent alleles of DLA-88, DLA-12/88L and DLA-DRB1 loci detected for 829 dogs. The allele frequency and the proportion of dogs with each allele are described by a bar and line chart, respectively. The allele names are indicated below each graph.
Figure 2. Top 20, 21 or 22 most frequent alleles of DLA-88, DLA-12/88L and DLA-DRB1 loci detected for 829 dogs. The allele frequency and the proportion of dogs with each allele are described by a bar and line chart, respectively. The allele names are indicated below each graph.
Cells 12 00809 g002
Cells 12 00809 g003
Figure 3. Phylogenetic relationship among the DLA-88, DLA-12, and DLA-88L allele sequences. (A) Neighbor-joining phylogenetic tree with exon 2–intron 2–exon 3 sequences of 109 alleles of DLA-88, DLA-12, and DLA-88L. The DLA-12 and DLA-88L alleles are represented with orange and red characters, respectively. Alleles that were not detected from 829 dogs in our study sample are indicated with a black-filled circle. Nucleotide sequences of H-2D and H-2K are used as an outgroup of the tree. (B) Dot-match analysis between two alleles by GenomeMatcher. The sequence similarity between DLA-88*nov65 and DLA-88*501:01, DLA-88*017:01 or DLA-12*004:01 are displayed by lines. The lines are colored based on the similarity score calculated by the bl2seq program with parameter as follow: word size 10 and e-value threshold 0.1. When the similarity score was lower than 90, the line was not described at the region. Dashed lines indicate the boundary of exon and intron in each allele.
Figure 3. Phylogenetic relationship among the DLA-88, DLA-12, and DLA-88L allele sequences. (A) Neighbor-joining phylogenetic tree with exon 2–intron 2–exon 3 sequences of 109 alleles of DLA-88, DLA-12, and DLA-88L. The DLA-12 and DLA-88L alleles are represented with orange and red characters, respectively. Alleles that were not detected from 829 dogs in our study sample are indicated with a black-filled circle. Nucleotide sequences of H-2D and H-2K are used as an outgroup of the tree. (B) Dot-match analysis between two alleles by GenomeMatcher. The sequence similarity between DLA-88*nov65 and DLA-88*501:01, DLA-88*017:01 or DLA-12*004:01 are displayed by lines. The lines are colored based on the similarity score calculated by the bl2seq program with parameter as follow: word size 10 and e-value threshold 0.1. When the similarity score was lower than 90, the line was not described at the region. Dashed lines indicate the boundary of exon and intron in each allele.
Cells 12 00809 g003
Cells 12 00809 g004
Figure 4. Comparisons of the proportion of dogs with each DLA-DRB1 allele in 10 breeds between the present Japanese and the previous UK study. Scatter plots based on the proportion of dogs with the DLA-DRB1 alleles in ten breeds are shown. The number of dogs analyzed and the number of observed alleles in the present Japanese and the previous UK study are described on the x- and y-axis in each plot, respectively. Dachshunds are summarized without classification by their size, such as miniature or kaninchen, and hair length, such as short or long, in both studies. An allele name is displayed alongside a marker when the proportion is above 5% in either the present or previous study. A red line in each plot represents a regression line. Also, a correlation coefficient (r) is indicated in each plot.
Figure 4. Comparisons of the proportion of dogs with each DLA-DRB1 allele in 10 breeds between the present Japanese and the previous UK study. Scatter plots based on the proportion of dogs with the DLA-DRB1 alleles in ten breeds are shown. The number of dogs analyzed and the number of observed alleles in the present Japanese and the previous UK study are described on the x- and y-axis in each plot, respectively. Dachshunds are summarized without classification by their size, such as miniature or kaninchen, and hair length, such as short or long, in both studies. An allele name is displayed alongside a marker when the proportion is above 5% in either the present or previous study. A red line in each plot represents a regression line. Also, a correlation coefficient (r) is indicated in each plot.
Cells 12 00809 g004
Cells 12 00809 g005
Figure 5. Percentage distribution of the 88-12/88L-DRB1 haplotypes in 24 breeds and mongrels. The cumulative bar chart is based on the frequency of all the 88-12/88L-DRB1 haplotypes detected from each breed listed in Table 5. A numeral following the breed’s name indicates the number of different haplotypes detected in each breed. Parenthesis indicates the number of different 88-12/88L-DRB1 haplotypes with a frequency of 5% or higher. The breeds are sorted in ascending order by the percentage frequency of the most frequent haplotype in each breed. For example, the graph of Miniature Schnauzer at the bottom of the figure represents a total of nine sub-haplotypes of 88-12/88L-DRB1 haplotypes with a frequency of 5% or higher for three of them at >50%, 10–29%, and 5–9%, respectively.
Figure 5. Percentage distribution of the 88-12/88L-DRB1 haplotypes in 24 breeds and mongrels. The cumulative bar chart is based on the frequency of all the 88-12/88L-DRB1 haplotypes detected from each breed listed in Table 5. A numeral following the breed’s name indicates the number of different haplotypes detected in each breed. Parenthesis indicates the number of different 88-12/88L-DRB1 haplotypes with a frequency of 5% or higher. The breeds are sorted in ascending order by the percentage frequency of the most frequent haplotype in each breed. For example, the graph of Miniature Schnauzer at the bottom of the figure represents a total of nine sub-haplotypes of 88-12/88L-DRB1 haplotypes with a frequency of 5% or higher for three of them at >50%, 10–29%, and 5–9%, respectively.
Cells 12 00809 g005
Cells 12 00809 g006
Figure 6. Principal component analysis based on 88-12/88L-DRB1 haplotype frequencies among 24 breeds. The analysis based on the frequency of three-locus DLA haplotypes in each allele at field-1 level among (A) 24 breeds listed in Table 5 and (B) 22 breeds except for Shetland Sheepdog and Miniature Schnauzer from (A) are represented. The breeds that shared a three-loci haplotype with relatively high frequency (See Section 3.6. in detail) are grouped with a red circle. The contribution ratio of the first (PC1) and second component (PC2) are described on the x- and y-axis in parentheses, respectively.
Figure 6. Principal component analysis based on 88-12/88L-DRB1 haplotype frequencies among 24 breeds. The analysis based on the frequency of three-locus DLA haplotypes in each allele at field-1 level among (A) 24 breeds listed in Table 5 and (B) 22 breeds except for Shetland Sheepdog and Miniature Schnauzer from (A) are represented. The breeds that shared a three-loci haplotype with relatively high frequency (See Section 3.6. in detail) are grouped with a red circle. The contribution ratio of the first (PC1) and second component (PC2) are described on the x- and y-axis in parentheses, respectively.
Cells 12 00809 g006
Cells 12 00809 g007
Figure 7. The cumulative percentage of dogs matched for homozygous 88-12/88L-DRB1 haplotypes detected in this study. The horizontal and vertical axes indicate 52 types of 88-12/88L-DRB1 homozygous haplotype numbers, which are sorted in descending order of the haplotype frequency, and the number of dogs, respectively. The cumulative proportion of dogs was calculated using the 803 dogs with identified haplotypes.
Figure 7. The cumulative percentage of dogs matched for homozygous 88-12/88L-DRB1 haplotypes detected in this study. The horizontal and vertical axes indicate 52 types of 88-12/88L-DRB1 homozygous haplotype numbers, which are sorted in descending order of the haplotype frequency, and the number of dogs, respectively. The cumulative proportion of dogs was calculated using the 803 dogs with identified haplotypes.
Cells 12 00809 g007
Table 1. Number of dogs in each of the 59 breeds and mongrels analyzed in this study.
Table 1. Number of dogs in each of the 59 breeds and mongrels analyzed in this study.
BreedNumber of Dogsa Rank of the Number of Dogs Registered in JapanBreedNumber of Dogsa Rank of the Number of Dogs Registered in Japan
Miniature Dachshund493Kaninchen Dachshund5
Toy Poodle441Bichon frize416
Golden Retriever4111Cairn Terrier4
Yorkshire Terrier418Japanese Spitz428
Beagle3924Pekingese419
Chihuahua392Standard Poodle4
Labrador Retriever3913Chin3
French Bulldog386Chinese Crested Dog3
Shiba379Doberman3
Shetland Sheepdog3523Great Pyrenees3
Miniature Schnauzer335Kooikerhondje3
Welsh Corgi3314Saint Bernard3
Pomeranian294Dalmatian2
Shih Tzu2810Norfolk Terrier2
Maltese267Weimaraner2
Papillon2415Basenji1
Pug2112Brussels Griffon1
American Cocker Spaniel2026Rough Collie1
Border Collie1918Irish Setter1
Cavalier King Charles Spaniel1822Lakeland Terrier1
Husky1227Leonberger1
Miniature Pinsher1221Miniature Bull Terrier1
Bernese Mountain Dog1129Rottweiler1
Bulldog1030Saluki1
Akita9 Shikoku1
Boston Terrier625Staffordshire Bull Terrier1
Italian Grey Hound620Toy Manchester
Terrier		1
Jack Russell Terrier617Wippet1
English Cocker Spaniel5 mongrel27
Flat-Coated Retriever5
German Shepherd5 Total829
a The data of a rank (top 30 most popular) of the number of dogs for each breed in Japan registered in 2022 is available from the Japan kennel club website (https://www.jkc.or.jp/ (accessed on 1 February 2023)).
Table 2. Summary of the DLA alleles detected from 829 dogs of 59 breeds.
Table 2. Summary of the DLA alleles detected from 829 dogs of 59 breeds.
LocusDLA-88DLA-12/88LDLA-DRB1
DLA-12DLA-88L
Number of Nucleotide Sequences Detected in This Study89251861
Previously published sequences72201155
Novel sequences17 (8)5 (2)7 (3)6 (4)
a Number of nucleotide sequences not detected in this study560-108
Number of unique amino acid sequences88211861
The number in the parenthesis of “Novel sequences” represents the number of allele sequences observed from two or more individuals in this study. The detailed information about all alleles detected in this study is described in Supplementary Table S2. a The numbers in the row indicate the number of registered sequences in the IPD-MHC database that were not detected in this study.
Table 3. Summary of the three-locus haplotypes assigned to 803 dogs of 49 breeds and mongrels.
Table 3. Summary of the three-locus haplotypes assigned to 803 dogs of 49 breeds and mongrels.
HaplotypeHaplotypes Detected Two or More TimesNumber of
Other Single
Haplotypes a		Frequency (%)Homozygote
Number of
Sub-Haplotypes		Number of
Haplotypes		Number of Sub-HaplotypesNumber of Dogs
DLA-88–DLA-12/88L–DRB1131154759-52198
two haplotype structures
DLA-88–DLA-12–DRB110112283679.442152
DLA-88–DLA-88L–DRB1303192320.61046
a The number represents the haplotypes that are observed just once from heterozygous dogs.
Table 4. The 29 most frequent 88-12/88L-DRB1 haplotypes found in this study.
Table 4. The 29 most frequent 88-12/88L-DRB1 haplotypes found in this study.
Haplotype
ID. a		DLA-88*DLA-12/88LDLA-DRB1*Number of HaplotypesHaplotypefrequency (%)Number of
Dogs with the Haplotypes		Number of Homozygous DogsNumber of Breeds with
the Haplotype Except for Mongrels c
DLA-12*DLA-88L b
(DLA-88*)
12004:02001:01:01 - 006:01684.2360810
20003:02 - 017:01002:01643.9945196 (Shetland Sheepdog (73.4%))
31003:02 - 017:01009:01643.9959511
25028:01 - 029:01015:02623.8652108
8501:01001:01:01 - 001:01533.304768
21508:01001:01:03 - 012:01503.114283
7012:01001:01:01 - 015:01482.994269
23013:02003:01 - 009:01462.8633132 (Miniature Schunauzer (95.7%))
116006:01001:01:01 - 056:01412.5531101 (Shiba (95.1%))
73051:01001:01:01 - 012:01402.493372 (Golden Retriever (85.0%))
6502:01001:01:01 - 001:02382.3728101 (Beagle (94.7%))
63004:02001:01:01 - 015:01342.1228614
18005:01002:04 - 020:01321.992849
17501:01001:01:01 - 006:01311.932748
2006:01001:01:01 - 006:01301.872468 (AmericanCocker Spaniel (70.0%))
51034:01002:03 - 023:01291.812365 (Shetland Sheepdog (75.9%))
91001:03001:01:01 - 046:01261.621881 (Papillon (96.2%))
46014:01:02001:05 - 025:01251.561964 (Shih Tzu (72.0%))
71002:01001:01:01 - 011:01231.432213
52006:01001:01:01 - 002:03231.432122 (Dachshund (78.3%))
66006:01001:01:01 - 001:01221.372206
10508:01001:01:03 - 002:01211.312107
22511:01001:03 - 015:02211.311923 (Laborador Retriever (90.5%))
99035:01nov18 - 006:01201.251552 (Shih Tzu (85.0%))
69054:01002:02 - 012:01201.251732 (Welsh Corgi (85.0%))
37006:01001:01:01 - 015:01181.121713 (Toy Poodle (77.8%))
48028:05 - 029:01015:02181.121806
33501:01001:01:01 - 012:01161.001605
117511:01001:03 - 092:01:1161.001511 (Shiba (87.5%))
a Haplotype ID. is identical to the number defined in Supplementary Table S3A. b All DLA-88L alleles as well as DLA-88 alleles are named with “DLA-88*” as a prefix. c The predominant breed in each haplotype, accounting for >70% of the detected number of haplotypes, is described in parenthesis, followed by the percentage of dogs with the haplotype in each of the predominant breeds.
Table 5. Genetic diversity indices of 25 breeds and mongrels based on three loci (88-12/88L-DRB1) haplotypes.
Table 5. Genetic diversity indices of 25 breeds and mongrels based on three loci (88-12/88L-DRB1) haplotypes.
BreedNumber of
Dogs a		Number of Estimated
Haplotypes		Number of
Homozygous Dogs		HoHeHWE TestFisHr b
Shetland Sheepdog35324 (68.6%)0.3140.450-0.3152.13
American Cocker Spaniel2059 (45.0%)0.5500.580p < 0.050.0772.94
Miniature Schunauzer32 (1)912 (37.5%)0.6250.510-−0.213.62
Cavalier King Charles Spaniel1865 (27.8%)0.7220.716p < 0.0010.0203.79
Shiba371114 (37.8%)0.6220.658p < 0.0010.0693.95
Golden Retriever39 (2)1111 (28.2%)0.7180.713p < 0.0010.0064.26
Papillon24910 (41.7%)0.5830.687p < 0.050.1714.60
Shih Tzu281210 (35.7%)0.6430.762p < 0.0010.2094.64
Miniature Pinsher1262 (16.7%)0.8330.771-−0.0384.64
Bernese Mountain Dog1173 (27.3%)0.7270.698-0.0064.79
French Bulldog381012 (31.6%)0.6840.751-0.1024.87
Husky1285 (41.7%)0.5830.733-0.2455.06
Beagle37 (2)1311 (29.7%)0.7030.730p < 0.050.0515.10
Bulldog1072 (20.0%)0.8000.790-0.0405.20
Labrador Retriever38 (1)157 (18.4%)0.8210.807p < 0.0010.0035.50
Welsh Corgi31 (2)95 (16.1%)0.8480.837-0.0155.62
Pomeranian29176 (20.7%)0.7930.757-−0.035.64
Yorkshire Terrier41133 (7.3%)0.9270.836-−0.0965.85
Pug21114 (19.0%)0.8100.840-0.0615.87
Maltese26135 (19.2%)0.8080.847-0.0666.02
Miniature Dachshund49155 (10.2%)0.8980.874-−0.0186.40
Border Collie19124 (21.1%)0.7890.871-0.1216.52
Chihuahua39202 (5.1%)0.9490.917-−0.0227.44
Toy Poodle44274 (9.1%)0.9090.927-0.0317.79
Mongrel27341 (3.7%)0.9630.962-0.0189.16
Ho: observed heterozygosity, He: expected heterozygosity, Fis: inbreeding coefficient, Hr: haplotype richness. a A number outside and inside the parenthesis indicates the number of dogs whose haplotype could be estimated and whose haplotype could not be estimated in each breed, respectively. b This table is sorted by the ascending order of the number of Hr. “-” in the column of the HWE test indicates no significant differences.
Table 6. The percentage of the dogs with the most frequent haplotype within each breed.
Table 6. The percentage of the dogs with the most frequent haplotype within each breed.
BreedHaplotype
ID. a		Most Frequent Haplotype in Each BreedThe Number of Dogs
with the Haplotype within the Breed (%)
DLA-88*DLA-12/88LDLA-DRB1*
DLA-12*DLA-88L b
(DLA-88*)
Miniature Schunauzer23013:02003:01 - 009:0132/33 (97.0)
Shetland Sheepdog20003:02 - 017:01002:0129/35 (82.9)
American Cocker Spaniel31003:02 - 017:01009:0116/20 (80.0)
Shiba116006:01001:01:01 - 056:0129/37 (78.4)
Pomeranian12004:02001:01:01 - 006:0122/29 (75.9)
Bernese Mountain Dog17501:01001:01:01 - 006:018/11 (72.7)
Papillon91001:03001:01:01 - 046:0117/24 (70.8)
Beagle6502:01001:01:01 - 001:0226/39 (66.7)
French Bulldog25028:01 - 029:01015:0225/38 (65.8)
Golden Retriever33501:01001:01:01 - 012:0126/41 (63.4)
Cavalier King Charles Spaniel71002:01001:01:01 - 011:0111/18 (61.1)
Yorkshire Terrier12004:02001:01:01 - 006:0124/41 (58.5)
Husky77060:02001:01:04 - 040:017/12 (58.3)
Labrador Retriever21508:01001:01:03 - 012:0121/39 (53.8)
Bulldog25028:01 - 029:01015:025/10 (50.0)
Miniature Pinscher63004:02001:01:01 - 015:016/12 (50.0)
ShihTzu46014:01:02001:05 - 025:0114/28 (50.0)
Welsh Corgi69054:01002:02 - 012:0115/33 (45.5)
Maltese7012:01001:01:01 - 015:0111/26 (42.3)
Miniature Dachshund8501:01001:01:01 - 001:0120/49 (40.8)
Pug110058:01 - 024:03010:0118/21 (38.1)
Border Collie24028:03 - 029:01015:026/19 (31.6)
Toy Poodle37006:01001:01:01 - 015:0113/44 (29.5)
Chihuahua30508:01001:01:03 - 015:0110/39 (25.6)
a Haplotype ID. is identical to the number defined in Supplementary Table S3A. b The prefix of official name for DLA-88L alleles is “DLA-88*”.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Miyamae, J.; Okano, M.; Katakura, F.; Kulski, J.K.; Moritomo, T.; Shiina, T. Large-Scale Polymorphism Analysis of Dog Leukocyte Antigen Class I and Class II Genes (DLA-88, DLA-12/88L and DLA-DRB1) and Comparison of the Haplotype Diversity between Breeds in Japan. Cells 2023, 12, 809. https://doi.org/10.3390/cells12050809

AMA Style

Miyamae J, Okano M, Katakura F, Kulski JK, Moritomo T, Shiina T. Large-Scale Polymorphism Analysis of Dog Leukocyte Antigen Class I and Class II Genes (DLA-88, DLA-12/88L and DLA-DRB1) and Comparison of the Haplotype Diversity between Breeds in Japan. Cells. 2023; 12(5):809. https://doi.org/10.3390/cells12050809

Chicago/Turabian Style

Miyamae, Jiro, Masaharu Okano, Fumihiko Katakura, Jerzy K. Kulski, Tadaaki Moritomo, and Takashi Shiina. 2023. "Large-Scale Polymorphism Analysis of Dog Leukocyte Antigen Class I and Class II Genes (DLA-88, DLA-12/88L and DLA-DRB1) and Comparison of the Haplotype Diversity between Breeds in Japan" Cells 12, no. 5: 809. https://doi.org/10.3390/cells12050809

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop